Author

R. H. Whitaker

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Corno· 1 shared A. T. Saurin· 1 shared B. L. Mouery· 1 shared B. Shi· 1 shared C. Spanos· 1 shared C. Zang· 1 shared H. Jiang· 1 shared J. G. Cook· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Corno

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivFeb 3, 2021

CDK4/6 inhibitors induce replication stress to cause long-term cell cycle withdrawal

L. Crozier, R. Foy, B. L. Mouery…·A. T. Saurin

This study shows CDK4/6 inhibitors cause long-term cell cycle withdrawal by inducing replication stress and p53-dependent effects, linking them to genotoxic stress and potential combination therapies.

DOI 10.15252/embj.2021108599

humanexperimental assay

𝕏 PostBluesky

Cancer BiologyExperimental Cell ResearchPeer-reviewedSep 1, 2019

Specific inhibition of DPY30 activity by ASH2L-derived peptides suppresses blood cancer cell growth

K. Shah, R. H. Whitaker, T. Busby…·H. Jiang

The paper develops DPY30-targeting peptides that inhibit blood cancer cell growth by disrupting ASH2L binding and H3K4 methylation.

DOI 10.1016/j.yexcr.2019.06.030

humanproteomics

𝕏 PostBluesky